{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/haematological-cancers-recognition-referral/how-this-topic-was-developed/evidence-exclusion-criteria/","result":{"pageContext":{"chapter":{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria","depth":2,"htmlHeader":"<!-- begin field 1495445b-410f-4a6d-860a-a7f201892e7f --><h2>Evidence exclusion criteria</h2><!-- end field 1495445b-410f-4a6d-860a-a7f201892e7f -->","summary":null,"htmlStringContent":"<!-- begin item dcf92f5e-5c59-4866-bcca-a7f20187a3cf --><!-- begin field adcdf56c-4993-44d7-b34a-a7f201892e7f --><h2>Our policy</h2><!-- end field adcdf56c-4993-44d7-b34a-a7f201892e7f --><!-- begin field 3301926c-74ff-465b-8e0b-a7f201892e7f --><p>Scoping a literature search, and reviewing the evidence for CKS is a methodical and systematic process that is carried out by the lead clinical author for each topic. Relevant evidence is gathered in order that the clinical author can make fully informed decisions and recommendations. It is important to note that some evidence may be excluded for a variety of reasons. These reasons may be applied across all CKS topics or may be specific to a given topic.</p><p>Studies identified during literature searches are reviewed to identify the most appropriate information to author a CKS topic, ensuring any recommendations are based on the best evidence. We use the principles of the GRADE and PICOT approaches to assess the quality of published research. We use the principles of AGREE II to assess the quality of published guidelines.</p><!-- end field 3301926c-74ff-465b-8e0b-a7f201892e7f --><!-- begin field 4bf8ea1b-736d-48e9-9180-a7f201892e7f --><h2>Standard exclusions for scoping literature:</h2><!-- end field 4bf8ea1b-736d-48e9-9180-a7f201892e7f --><!-- begin field 7231022f-45a9-4643-a8eb-a7f201892e7f --><ul><li>Animal studies</li><li>Original research is not written in English</li></ul><!-- end field 7231022f-45a9-4643-a8eb-a7f201892e7f --><!-- begin field 50ff1029-93a5-4998-8338-a7f201892e7f --><h2>Possible exclusions for reviewed literature:</h2><!-- end field 50ff1029-93a5-4998-8338-a7f201892e7f --><!-- begin field 519773f3-42aa-483c-95c4-a7f201892e7f --><ul><li>Sample size too small or study underpowered</li><li>Bias evident or promotional literature</li><li>Population not relevant</li><li>Intervention/treatment not relevant</li><li>Outcomes not relevant</li><li>Outcomes have no clear evidence of clinical effectiveness</li><li>Setting not relevant</li><li>Not relevant to UK</li><li>Incorrect study type</li><li>Review article</li><li>Duplicate reference</li></ul><!-- end field 519773f3-42aa-483c-95c4-a7f201892e7f --><!-- end item dcf92f5e-5c59-4866-bcca-a7f20187a3cf -->","topic":{"id":"7a666688-628e-59c5-9e49-275e6df96c89","topicId":"efd78d5c-f39b-47aa-a99a-712fcd440511","topicName":"Haematological cancers - recognition and referral","slug":"haematological-cancers-recognition-referral","lastRevised":"Last revised in February 2021","chapters":[{"id":"1b99cc60-959f-5937-a54d-248dd557eb06","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"f3b3ad5d-37b7-5a29-8e71-51338dfd53d0","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"77a57871-2fdc-584c-9148-924a40f28c72","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"1b4978ef-a636-510a-b98b-df2c1d638607","slug":"changes","fullItemName":"Changes"},{"id":"31156ad7-e1ac-50f7-a238-d5ab91d07500","slug":"update","fullItemName":"Update"}]},{"id":"dfef533d-7728-5775-8f82-3e745c90c505","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"388024d8-7d15-587b-8988-d7c628863b80","slug":"goals","fullItemName":"Goals"},{"id":"c513e6cc-f297-57a6-adef-8b1e4f1f8f2c","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"7e3cb3e7-e51c-5962-8394-f4e0a6813935","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"3aaac357-49bc-50e7-9bc7-f68a75f8f23b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"f422ee8f-401a-55f0-af2e-ec46fece5aba","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7a906314-79dc-5a14-86d9-f6c963dbfaf0","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0205c796-921c-5df9-aa6e-52892106204f","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"0075cdde-2c8e-5e7d-9734-e640651b657b","slug":"presentation","fullItemName":"Presentation"},{"id":"76cd470e-5904-5537-8ec0-73d5a2425747","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0fbae03d-8109-54c7-ad40-6ad26a3ae1b4","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"f824311f-b5dd-585e-bda3-3f418f0cd768","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"399985ab-242f-53f8-8852-45b946548d09","slug":"symptoms-suggestive-of-haematological-cancers","fullItemName":"Symptoms suggestive of haematological cancers"},{"id":"129bfa10-e11b-5bf8-aeac-2ec5de9171d7","slug":"investigations-in-primary-care","fullItemName":"Investigations in primary care"}]},{"id":"e4e9d509-0950-59c5-9f10-397475616fe8","fullItemName":"Management","slug":"management","subChapters":[{"id":"cfe47d3f-300b-5be4-b4da-3dd966fef722","slug":"referral-for-haematological-cancer","fullItemName":"Scenario: Referral for haematological cancer"}]},{"id":"61fcee5d-ff66-5a4c-91e7-4f497dfcc559","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"f9e3a44b-54f7-5761-b0f1-43617129d77e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"13a9be84-5d20-5ab3-8ea3-6490e30776d4","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e1c7b25a-a475-5f05-a2da-9d859d501051","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9ed371b-e3f7-510a-a3f5-e7c55990b468","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"ff05ddf2-8028-5120-8912-94378fd8dc5a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f7896863-2653-51f8-8deb-f8525add21d6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"ae7d0bdc-fc33-577f-9cfe-009a08676afa","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}